REKAHRR

REKAH

1,377ILAD
+28+2.08%
At close at 14:24 GMT
ILA
No trades
See on Supercharts
Market capitalization
‪153.98 M‬ILS
‪6.21 M‬ILS
‪321.71 M‬ILS
‪1.88 M‬
Beta (1Y)
0.83
Employees (FY)
447
Change (1Y)
−8 −1.76%
Revenue / Employee (1Y)
‪719.71 K‬ILS
Net income / Employee (1Y)
‪13.88 K‬ILS

About REKAH


CEO
Mordechai Algrably
Headquarters
Holon
Founded
1947
ISIN
IL0010810096
FIGI
BBG000BV7B79
Rekah Pharmaceutical Industry Ltd. engages in the manufacture, import, marketing, sale, registration, and distribution of generic drugs, cosmetics, vitamins, and nutritional supplements. It operates through the following segments: Core Products, Distribution, and Others. The Core Products segment manufactures medicines, medical cosmetic products, vitamins, and nutritional supplements under the company's name or brands. The Distribution segment deals with marketing, sale, and distribution of medicines, cosmetic products, vitamins and nutritional supplements, consumer products, and any other product that is sold or distributed by the company as part of the company's sales and distribution agreements with third party suppliers. The Others segment includes concession for the distribution of lottery in the Jerusalem and Modi'in area. The company was founded in 1947 and is headquartered in Holon, Israel.
Performance
‪−6%‬
‪0%‬
‪6%‬
‪12%‬
‪18%‬
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−30.00 M‬‬
‪0.00‬
‪‪30.00 M‬‬
‪‪60.00 M‬‬
‪‪90.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−26.00 M‬‬
‪0.00‬
‪‪26.00 M‬‬
‪‪52.00 M‬‬
‪‪78.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−26.00 M‬‬
‪0.00‬
‪‪26.00 M‬‬
‪‪52.00 M‬‬
‪‪78.00 M‬‬
Debt level and coverage
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of REKA is 1,377 ILA — it has increased by 2.08% in the past 24 hours. Watch REKAH stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange REKAH stocks are traded under the ticker REKA.
REKA stock has risen by 8.35% compared to the previous week, the month change is a 16.29% rise, over the last year REKAH has showed a 8.00% increase.
REKA reached its all-time high on Jun 3, 2013 with the price of 5,993 ILA, and its all-time low was 369 ILA and was reached on Feb 25, 2009. View more price dynamics on REKA chart.
See other stocks reaching their highest and lowest prices.
REKA stock is 2.30% volatile and has beta coefficient of 0.83. Track REKAH stock price on the chart and check out the list of the most volatile stocks — is REKAH there?
Today REKAH has the market capitalization of ‪143.25 M‬, it has increased by 1.54% over the last week.
Yes, you can track REKAH financials in yearly and quarterly reports right on TradingView.
REKA net income for the last quarter is ‪−2.32 M‬ ILS, while the quarter before that showed ‪−4.67 M‬ ILS of net income which accounts for 50.35% change. Track more REKAH financial stats to get the full picture.
As of May 21, 2025, the company has 447 employees. See our rating of the largest employees — is REKAH on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REKAH EBITDA is ‪26.82 M‬ ILS, and current EBITDA margin is 8.34%. See more stats in REKAH financial statements.
Like other stocks, REKA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REKAH stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So REKAH technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating REKAH stock shows the sell signal. See more of REKAH technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.